PULSE BIOSCIENCES, INC. — Director's Dealing 2017

Aug 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-08-02

Reporting Person: Zanganeh Maky (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-02	Common Stock	P	8290	$25.147	Acquired	287225	Direct
2017-08-03	Common Stock	P	6000	$23.227	Acquired	293225	Direct
2017-08-03	Common Stock	P	9500	$23.89	Acquired	302725	Direct
2017-08-03	Common Stock	P	5000	$23.003	Acquired	90474	Indirect

Footnotes

F1: This is the weighted average purchase price of the shares, which ranged from $24.97 to $25.25 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F2: This is the weighted average purchase price of the shares, which ranged from $22.80 to $23.79 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F3: This is the weighted average purchase price of the shares, which ranged from $23.80 to $24.04 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F4: This is the weighted average purchase price of the shares, which ranged from $22.78 to $23.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.